KD Logo

BridgeBio Pharma Inc [BBIO] Records 200-Day SMA of $28.99

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BridgeBio Pharma Inc shares valued at $2,558,025 were sold by Kumar Neil on Apr 22 ’25. At $34.11 per share, Kumar Neil sold 75,000 shares. The insider’s holdings dropped to 4,873,447 shares worth approximately $175.25 million following the completion of this transaction.

Also, Ellis Andrea sold 10,000 shares, netting a total of over 350,000 in proceeds. Following the sale of shares at $35.00 each, the insider now holds 12,000 shares.

Before that, ANDREA ELLIS had added 10,000 shares to its account. In a trade valued at $350,000, the Director bought BridgeBio Pharma Inc shares for $35.00 each.

As published in their initiating research note from Redburn Atlantic on March 31, 2025, BridgeBio Pharma Inc [BBIO] has been a Buy and the price target has been revised to $50. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of October 03, 2024, Oppenheimer has initiated its “Perform” rating for BBIO. Earlier on September 04, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for BBIO stock.

Analyzing BBIO Stock Performance

During the last five days, there has been a surge of approximately 6.23%. Over the course of the year, BridgeBio Pharma Inc shares have jumped approximately 31.05%. Shares of the company reached a 52-week high of $39.47 on 02/20/25 and a 52-week low of $27.53 on 01/02/25. A 50-day SMA is recorded $33.93, while a 200-day SMA reached $28.99.

Support And Resistance Levels for BridgeBio Pharma Inc (BBIO)

According to the 24-hour chart, there is a support level at 35.12, which, if violated, would cause prices to drop to 34.27. In the upper region, resistance lies at 36.40. The next price resistance is at 36.83. RSI (Relative Strength Index) is 58.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.77, which suggests the price will increase in the coming days. Percent R is at 1.93%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular